Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organogenesis Holdings Inc

4.99
+0.02000.40%
Volume:1.15M
Turnover:5.77M
Market Cap:632.87M
PE:-499.00
High:5.21
Open:4.95
Low:4.88
Close:4.97
Loading ...

Organogenesis (ORGO) Q3 2024 Earnings Call Transcript

Motley Fool Transcribing
·
13 Nov 2024

Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates

Zacks
·
13 Nov 2024

Organogenesis: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

Organogenesis Hldgs Q3 2024 Adj. EPS $0.10 Beats $(0.01) Estimate, Sales $115.177M Beat $108.833M Estimate

Benzinga
·
13 Nov 2024

Organogenesis announces $130M private placement offering

TIPRANKS
·
13 Nov 2024

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series a Convertible Preferred Stock

THOMSON REUTERS
·
13 Nov 2024

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

GlobeNewswire
·
13 Nov 2024

Organogenesis Gets Favorable Recommendation on 2nd Phase 3 Knee Osteoarthritis Trial; Shares Up

MT Newswires Live
·
12 Nov 2024

Organogenesis provides update on Phase 3 trial of ReNu in knee osteoarthritis

TIPRANKS
·
12 Nov 2024

Organogenesis Holdings Inc - DMC Finds Safety Data Consistent With Known Profile for Renu

THOMSON REUTERS
·
12 Nov 2024

Organogenesis Holdings Inc - DMC Recommends Phase 3 Trial of Renu Proceed Without Modification

THOMSON REUTERS
·
12 Nov 2024

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of Renu for Knee Osteoarthritis

THOMSON REUTERS
·
12 Nov 2024

Organogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
09 Nov 2024

Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years ago

Simply Wall St.
·
30 Oct 2024

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

GlobeNewswire
·
16 Oct 2024